Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Clinical and Quality of Life Predictors of Failure to Achieve Event Free Survival at 24 Months in Patients Aged 70 Years and Older with Diffuse Large B-Cell Lymphoma

Patrick M. Reagan, MD, Andrea M Baran, MS, Matthew J. Maurer, MS, Andrew L. Feldman, MD, Thomas M. Habermann, MD, Susan L. Slager, PhD, Gita Thanarajasingam, MD, Kathleen J Yost, PhD, Brian K. Link, MD, James R. Cerhan, MD PhD, Carrie A. Thompson, MD

Blood (2018) 132 (Supplement 1): 3579.

https://doi.org/10.1182/blood-2018-99-118356

Published: 2018

Journal Articles

Sustained Improvements in Fatigue and Quality of Life in Iron Deficiency Anemia Patients Following a Single Course of Ferumoxytol: Results of a 6-Month Extension Study

Saroj Vadhan-Raj, MD, Naomi V Dahl, PharmD, John Jiang, PhD, William E Strauss, MD

Blood (2018) 132 (Supplement 1): 1050.

https://doi.org/10.1182/blood-2018-99-115511

Published: 2018

Journal Articles

A Pilot Study Evaluating the Impact of Hospital Hospitality Houses (HHH) Programs on the Quality of Life and Mood of Patients and Their Caregivers Following Hematopoietic Stem Cell Transplant (HCT)

Maria Emma Torres, Shahrukh K. Hashmi, MDMPH, Angelina Tan, Jeff A. Sloan, PhD, Maria Stevens, Valerie Callahan, Gerardo Colon-Otero, MD

Blood (2017) 130 (Supplement 1): 5607.

https://doi.org/10.1182/blood.V130.Suppl_1.5607.5607

Published: 2017

Journal Articles

Usage of Patient-Centered Outcomes in the Management of Anemia: A Systematic Review

Phillip Staibano, BSc, MSc, Julia Lombardi, BSc, Iris Perelman, BHSc, Alexandra Davis, BA, MLIS, Alan T. Tinmouth, MD FRCPC, Marc Carrier, MD, Elianna Saidenberg, MD

Blood (2017) 130 (Supplement 1): 5646.

https://doi.org/10.1182/blood.V130.Suppl_1.5646.5646

Published: 2017

Journal Articles

Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies

Carrie A Thompson, MD, Paul Novotny, Jeff A. Sloan, PhD, Alicia Bartz, Kathleen Yost, PhD

Blood (2017) 130 (Supplement 1): 2179.

https://doi.org/10.1182/blood.V130.Suppl_1.2179.2179

Published: 2017

Journal Articles

Changes in Quality of Life in Indolent Non-Hodgkin Lymphoma 3 Years after Diagnosis

Carrie A Thompson, MD, Kathleen Yost, PhD, Melissa C. Larson, M.S., Cristine Allmer, BS, Matthew J Maurer, MS, Amylou C. Dueck, PhD, Tait D. Shanafelt, MD, Thomas M Habermann, MD, Allison C. Rosenthal, DO, Umar Farooq, MD, Brian K Link, MD, James R Cerhan, MD PhD

Blood (2017) 130 (Supplement 1): 917.

https://doi.org/10.1182/blood.V130.Suppl_1.917.917

Published: 2017

Journal Articles

Duration Matters: Impact of Time from Diagnosis on Symptoms in Patients with Hematologic Malignancies

Leslie Padrnos, MD, Heidi Kosiorek, MS, Robert M Bennett, III, Amylou Constance Dueck, PhD, Krisstina L. Gowin, DO, Robyn M. Scherber, MD, Holly L. Geyer, MD, Jeanne Palmer, MD, Donald Northfelt, MD, Joseph R Mikhael, MD FRCPC, MD, Nandita Khera, MD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2162.

https://doi.org/10.1182/blood.V130.Suppl_1.2162.2162

Published: 2017

Journal Articles

Results of the First American Prospective Study of IV Iron in Oral Iron Intolerant Iron Deficient Gravidas

Michael Auerbach, MD, Samuel Smith, MD, Stephanie James, MD

Blood (2016) 128 (22): 1277.

https://doi.org/10.1182/blood.V128.22.1277.1277

Published: 2016

Journal Articles

Quality of Life at Diagnosis Independently Predicts Survival in Patients with Aggressive Lymphoma

Carrie A Thompson, MD, Matthew J Maurer, MS, Cristine Allmer, Susan L Slager, PhD, Kathleen Yost, PhD, William R Macon, MD, Stephen M. Ansell, MD PhD, David J. Inwards, MD, Thomas M Habermann, MD, Brian K Link, MD, James R Cerhan, MD PhD

Blood (2014) 124 (21): 205.

https://doi.org/10.1182/blood.V124.21.205.205

Published: 2014

Journal Articles

Ferumoxytol Treatment Demonstrates Significant Improvements in Fatigue and Health-Related Quality of Life in Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy

Saroj Vadhan Raj, Andrew Hsieh, William Strauss, M.D., F.A.C.C., Michael Stevenson, R.Ph., Ph.D., Kristine Bernard, Lee F. Allen, MD, PhD

Blood (2012) 120 (21): 478.

https://doi.org/10.1182/blood.V120.21.478.478

Published: 2012

Journal Articles

Role of Iron Supplementation to Erythropoiesis Stimulating Agents In the Management of Chemotherapy-Induced Anemia In Cancer Patients: A Systematic Review and Meta-Analysis

Rahul Mhaskar, MD, MPH, Hesborn Wao, PhD., Ambuj Kumar, MD, MPH, Branko Miladinovic, PhD, Benjamin Djulbegovic, MD, PhD

Blood (2010) 116 (21): 2055.

https://doi.org/10.1182/blood.V116.21.2055.2055

Published: 2010

Journal Articles

Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.

Esther Natalie Oliva, MD, Valeria Santini, MD, Poloni Antonella, MD, Vincenzo Liso, MD, Daniela Cilloni, MD, Adelmo Terenzi, MD, Patrizia Guglielmo, MD, Riccardo Ghio, MD, Agostino Cortelezzi, MD, Giampietro Semenzato, MD, Cristina Clissa, MD, Flavia Salvi, MD, Oreste Villani, MD, Maria Antonietta Aloe Spiriti, MD

Blood (2009) 114 (22): 3822.

https://doi.org/10.1182/blood.V114.22.3822.3822

Published: 2009

Journal Articles

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

David P Steensma, MD, Shaker R. Dakhil, MD, Robert Dalton, MD, Stephen P Kahanic, MD, John W Kugler, MD, Philip J Stella, MD, Kendrith M Rowland, Jr., MD, Paul J Novotny, MS, Jeff A Sloan, PhD, Charles L Loprinzi, MD

Blood (2009) 114 (22): 630.

https://doi.org/10.1182/blood.V114.22.630.630

Published: 2009

Journal Articles

A Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week Epoetin Alfa and Every-3-Week Darbepoetin Alfa: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

David P Steensma, MD, Shaker R. Dakhil, MD, Paul J Novotny, MS, Jeff A Sloan, PhD, David B Johnson, MD, Daniel M Anderson, MD, Bassam I Mattar, MD, Dennis F Moore, Jr., MD, Daniel Nikcevich, MD, PhD, Charles L Loprinzi, MD

Blood (2009) 114 (22): 3008.

https://doi.org/10.1182/blood.V114.22.3008.3008

Published: 2009

Journal Articles

Quality of Life Assessment in Patients Affected by Myelodysplastic Syndrome

Esther Natali e Oliva, MD, Cristina Clissa, MD, Valeria Santini, Antonella Poloni, MD, Vincenzo Liso, MD, Daniela Cilloni, MD, PhD, Adelmo Terenzi, MD, Stefana Impera, MD, Alessandro Levis, MD, Agostino Cortelezzi, MD, Riccardo Ghio, MD, Giampietro Semenzato, MD, Oreste Villani, MD, Maria Antonietta Aloe Spiriti, MD

Blood (2008) 112 (11): 2363.

https://doi.org/10.1182/blood.V112.11.2363.2363

Published: 2008

Journal Articles

Epoetin alfa 80,000 U Every Three Weeks (Q3W) in Anemic Cancer Patients (pts) Not Receiving Chemotherapy (CT) or Radiation Therapy (RT).

Daniel Shasha, MD, Fitzroy Dawkins, MD, Francois E. Wilhelm, MD,PhD,MSc

Blood (2006) 108 (11): 3755.

https://doi.org/10.1182/blood.V108.11.3755.3755

Published: 2006

Journal Articles

Quality of Life Concerns of Long-Term Lymphoma Survivors: Results of a Pilot Study.

Jeff A. Sloan, PhD, Matthew M. Clark, PhD, Carol A. Janney, MS, Teresa A. Rummans, MD, Susan M. Geyer, PhD, James R. Cerhan, MD, PhD, Thomas M. Habermann, MD

Blood (2005) 106 (11): 4695.

https://doi.org/10.1182/blood.V106.11.4695.4695

Published: 2005

Journal Articles

Increasing Hemoglobin Levels with Epoetin Alfa in Anemic Hematologic Cancer Patients Receiving Chemotherapy Correlates Significantly with Improved Quality of Life.

Jean-Luc Harousseau, Pierre Fumoleau, Winand Lange, Manfred Welslau

Blood (2004) 104 (11): 2213.

https://doi.org/10.1182/blood.V104.11.2213.2213

Published: 2004

Journal Articles

Greater Area under the Hemoglobin Change Curve Is Associated with Improved Outcomes in Elderly Patients Receiving Epoetin Alfa for Chemotherapy-Related Anemia.

Scott R. McKenzie, MD, Mei S. Duh, MPH, ScD, Patrick Lefevbre, MA, John M. Fastenau, MPH, RPh, Catherine Tak Piech, MBA

Blood (2004) 104 (11): 3146.

https://doi.org/10.1182/blood.V104.11.3146.3146

Published: 2004

Journal Articles

Epoetin Alfa 40,000 U QW Increases Hb and Is Safe in Anemic Patients with Cancer Not Receiving Chemotherapy or Radiation Therapy.

Daniel Shasha, MD, Denise Williams, MD.

Blood (2004) 104 (11): 4223.

https://doi.org/10.1182/blood.V104.11.4223.4223

Published: 2004

NARROW

Clinical and Quality of Life Predictors of Failure to Achieve Event Free Survival at 24 Months in Patients Aged 70 Years and Older with Diffuse Large B-Cell Lymphoma

Sustained Improvements in Fatigue and Quality of Life in Iron Deficiency Anemia Patients Following a Single Course of Ferumoxytol: Results of a 6-Month Extension Study

A Pilot Study Evaluating the Impact of Hospital Hospitality Houses (HHH) Programs on the Quality of Life and Mood of Patients and Their Caregivers Following Hematopoietic Stem Cell Transplant (HCT)

Usage of Patient-Centered Outcomes in the Management of Anemia: A Systematic Review

Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies

Changes in Quality of Life in Indolent Non-Hodgkin Lymphoma 3 Years after Diagnosis

Duration Matters: Impact of Time from Diagnosis on Symptoms in Patients with Hematologic Malignancies

Results of the First American Prospective Study of IV Iron in Oral Iron Intolerant Iron Deficient Gravidas

Quality of Life at Diagnosis Independently Predicts Survival in Patients with Aggressive Lymphoma

Ferumoxytol Treatment Demonstrates Significant Improvements in Fatigue and Health-Related Quality of Life in Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy

Role of Iron Supplementation to Erythropoiesis Stimulating Agents In the Management of Chemotherapy-Induced Anemia In Cancer Patients: A Systematic Review and Meta-Analysis

Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

A Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week Epoetin Alfa and Every-3-Week Darbepoetin Alfa: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

Quality of Life Assessment in Patients Affected by Myelodysplastic Syndrome

Epoetin alfa 80,000 U Every Three Weeks (Q3W) in Anemic Cancer Patients (pts) Not Receiving Chemotherapy (CT) or Radiation Therapy (RT).

Quality of Life Concerns of Long-Term Lymphoma Survivors: Results of a Pilot Study.

Increasing Hemoglobin Levels with Epoetin Alfa in Anemic Hematologic Cancer Patients Receiving Chemotherapy Correlates Significantly with Improved Quality of Life.

Greater Area under the Hemoglobin Change Curve Is Associated with Improved Outcomes in Elderly Patients Receiving Epoetin Alfa for Chemotherapy-Related Anemia.

Epoetin Alfa 40,000 U QW Increases Hb and Is Safe in Anemic Patients with Cancer Not Receiving Chemotherapy or Radiation Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only